Wechselwirkungen · Viramune
Viramune 200 mg tablets · Abschnitt 4.5 · PDF-Seite 9
HOS-088085 · Präparat HOS-083615
Zidovudine Zidovudine AUC 0.72 Zidovudine and Viramune can be 100-200 mg TID (0.60-0.96) co-administered without dose Zidovudine Cmin ND adjustments Zidovudine Cmax 0.70 (0.49-1.04) Granulocytopenia is commonly Nevirapine: Zidovudine had no associated with zidovudine. effect on its pharmacokinetics. Therefore, patients who receive nevirapine and zidovudine concomitantly and especially paediatric patients and patients who receive higher zidovudine doses or patients with poor bone marrow reserve, in particular those with advanced HIV disease, have an increased risk of granulocytopenia. In such patients haematological parameters should be carefully monitored.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): zidovudine (HOS-085837)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-07T09:26:00Z · SHA-256 3124c3838448e2e235ceba5ac8568ac2aa499d31c735f56f78ff4d70c1cb2cc3 · Passage 22b64b240acdbdd454c3f1cfb651df4104e96a9c872dafd5a9aa4d01f85f7f1d · Zeichen 3186–4648 im Abschnitt